CN Patent

CN120569377A — 一种四氢噻吩衍生物及其在医药上的应用

Assigned to Haisco Pharmaceutical Group Co Ltd · Expires 2025-08-29 · 1y expired

What this patent protects

一种通式(I)所述的化合物或者其立体异构体、氘代物、溶剂化物、前药、代谢产物、药学上可接受的盐或共晶，及其中间体和制备方法，以及在制备治疗疼痛的药物中的应用。

USPTO Abstract

一种通式(I)所述的化合物或者其立体异构体、氘代物、溶剂化物、前药、代谢产物、药学上可接受的盐或共晶，及其中间体和制备方法，以及在制备治疗疼痛的药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN120569377A
Jurisdiction
CN
Classification
—
Expires
2025-08-29
Drug substance claim
No
Drug product claim
No
Assignee
Haisco Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.